News The rise and fall of treatment trials in group 3 pulmonary hypertension: Where do we go from here? Author: Christopher King, MD, FCCP Publish date: December 6, 2017 Treatment of fibrotic interstitial lung disease (ILD) is often dissatisfying to clinicians and patients. Despite significant advances in the field... Read More
